Sign Up to like & get recommendations! 0
Published in 2020 at "Research in veterinary science"
DOI: 10.1016/j.rvsc.2020.01.002
Abstract: It was the aim of the study to assess the impact of a minor surgical intervention under general anaesthesia on results of a low-dose dexamethasone suppression test (LDDST) in dogs. Five clinically healthy dogs underwent… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Surgery"
DOI: 10.1016/j.surg.2020.05.046
Abstract: BACKGROUND The diagnostic threshold for mild autonomous cortisol secretion using low dose, overnight, dexamethasone suppression testing is recognized widely as a serum cortisol ≥1.8 mcg/dL. The degree to which these patients require postoperative glucocorticoid replacement… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Annals of Clinical Biochemistry"
DOI: 10.1177/0004563219870834
Abstract: Background In the evaluation for hypercortisolism (Cushing’s syndrome), the 1 mg overnight dexamethasone suppression test has an important role, but false-positive results can occur due to low serum dexamethasone. Given the high intraindividual reproducibility of post-dexamethasone… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Annals of clinical biochemistry"
DOI: 10.1177/00045632231179560
Abstract: BACKGROUND The 1 mg overnight dexamethasone suppression test (ONDST) is recommended for the differential diagnosis of Cushing's syndrome and the investigation of adrenal incidentalomas. Despite documented variation in serum cortisol immunoassay performance, little has been… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Endocrine journal"
DOI: 10.1507/endocrj.ej17-0083
Abstract: The low-dose dexamethasone suppression test (DST) is one of the commonly used initial tests for endogenous Cushing's syndrome (CS). However, there are two loading dose regimens (0.5-mg and 1-mg), which may cause some confusion in… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Endocrine Regulations"
DOI: 10.2478/enr-2022-0028
Abstract: Abstract Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients. Methods. Anthropometric measurements and other laboratory… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm13050837
Abstract: The dexamethasone suppression test (DST) assesses the functionality of the HPA axis and can be regarded as the first potential biomarker in psychiatry. In 1981, a group of researchers at the University of Michigan published… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Molecules"
DOI: 10.3390/molecules28010248
Abstract: The simultaneous measurement of dexamethasone and cortisol has proven the ability to increase the diagnostic performance of the overnight dexamethasone-suppression test. Furthermore, the therapeutic drug monitoring of administered corticosteroid drugs could represent a crucial tool… read more here.